Champions Biotechnology, Inc: Tumor Xenotransplantation

Article

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts� ("tumor xenograft") that is being developed by researchers at Champion.

Douglas Burkett, PhD, president of Champion Biotechnology Inc, discusses the Biomerk Tumorgrafts™ (“tumor xenograft”) that is being developed by researchers at Champion.

Recent Videos
Ashfaq Marghoob, MD: Artificial Intelligence, Smartphone Use for Pigmented Lesion Classification
Steve Nissen, MD | Credit: Cleveland Clinic
Major Diagnostic Challenges for Pigmented Lesions, with Ashfaq Marghoob, MD
Considering Viral Infections in Patients With Rheumatic Disease With Leonard Calabrese, DO
Benjamin Scirica, MD | Credit: Brigham and Women's Hospital
Nihar Desai, MD | Credit: HCPLive.com
Laurence Sperling, MD | Credit: Emory University
Leonard H. Calabrese, DO, Professor of Medicine and Vice Chair, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University
Acne and Rosacea Updates 2024, with James Del Rosso, DO
© 2024 MJH Life Sciences

All rights reserved.